Boyer, P.; Danion, J.M.; Bisserbe, J.C.; Hotton, J.M.; … - In: PharmacoEconomics 13 (1998) 1 Part 2, pp. 157-169
In a double-blind study in a primary-care setting in France, outpatients fulfilling DSM IV criteria for a major depressive episode were randomised to receive sertraline (50 to 150 mg/day; n = 122) or fluoxetine (20 to 60 mg/day; n = 120). Assessments, including clinical evaluation...
